Cargando…

(13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer

SIMPLE SUMMARY: Bladder cancer (BC) is a common urological cancer and has a high incidence of recurrence. Metabolic changes are one of the hallmarks of cancer. Differences in metabolic pathways between normal and cancerous tissues lead to a heterogeneous distribution of natural isotope abundance. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Madej, Adam, Forma, Ewa, Golberg, Michał, Kamiński, Rafał, Paneth, Piotr, Kobos, Józef, Różański, Waldemar, Lipiński, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140021/
https://www.ncbi.nlm.nih.gov/pubmed/35626027
http://dx.doi.org/10.3390/cancers14102423
_version_ 1784714997044084736
author Madej, Adam
Forma, Ewa
Golberg, Michał
Kamiński, Rafał
Paneth, Piotr
Kobos, Józef
Różański, Waldemar
Lipiński, Marek
author_facet Madej, Adam
Forma, Ewa
Golberg, Michał
Kamiński, Rafał
Paneth, Piotr
Kobos, Józef
Różański, Waldemar
Lipiński, Marek
author_sort Madej, Adam
collection PubMed
description SIMPLE SUMMARY: Bladder cancer (BC) is a common urological cancer and has a high incidence of recurrence. Metabolic changes are one of the hallmarks of cancer. Differences in metabolic pathways between normal and cancerous tissues lead to a heterogeneous distribution of natural isotope abundance. We analyzed the isotope ratio of carbon, nitrogen, and sulfur in normal urothelium and bladder cancer samples and correlated these data with clinical parameters. We found that bladder cancers are (13)C- and (15)N-depleted when compared to normal urothelium. Furthermore, decreased (13)C abundance in normal urothelium is correlated with shorter disease-free survival in bladder cancer patients. Determination of the isotopic signature of normal and cancerous bladder biopsies can provide important information about the risk of recurrence and improve patients’ management by avoiding invasiveness and unnecessary diagnostic procedures such as cystoscopy. ABSTRACT: Bladder cancer (BC) is the most common urological malignancy and has a high incidence of recurrence. BC cells alter their nutrient uptake and metabolic pathways in order to continue the production of sufficient levels of ATP and metabolic intermediates for proliferation and survival. Changes in metabolic pathways regarding the rate of the enzymatic reaction and transport lead to differences in the content of natural isotopes ((13)C, (15)N, (34)S) between normal and cancerous tissues. The assessment of the stable isotopes of carbon, nitrogen, and sulfur in normal urothelium and bladder cancer samples was performed using Isotope Ratio Mass Spectrometry (IRMS). The natural abundance of (15)N and (13)C was decreased in bladder cancer samples when compared to normal urothelium. No significant correlation was observed in BC specimens depending on the tumor grade and stage. Samples derived from bladder tumors and normal urothelium had a different pattern of (15)N and (13)C isotope abundance. Decreased (13)C natural isotopes in the normal urothelium of BC patients were significantly associated with a shorter DFS. Our results suggest that isotopic analysis of normal urothelium of BC patients can be used to predict bladder cancer recurrence.
format Online
Article
Text
id pubmed-9140021
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91400212022-05-28 (13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer Madej, Adam Forma, Ewa Golberg, Michał Kamiński, Rafał Paneth, Piotr Kobos, Józef Różański, Waldemar Lipiński, Marek Cancers (Basel) Article SIMPLE SUMMARY: Bladder cancer (BC) is a common urological cancer and has a high incidence of recurrence. Metabolic changes are one of the hallmarks of cancer. Differences in metabolic pathways between normal and cancerous tissues lead to a heterogeneous distribution of natural isotope abundance. We analyzed the isotope ratio of carbon, nitrogen, and sulfur in normal urothelium and bladder cancer samples and correlated these data with clinical parameters. We found that bladder cancers are (13)C- and (15)N-depleted when compared to normal urothelium. Furthermore, decreased (13)C abundance in normal urothelium is correlated with shorter disease-free survival in bladder cancer patients. Determination of the isotopic signature of normal and cancerous bladder biopsies can provide important information about the risk of recurrence and improve patients’ management by avoiding invasiveness and unnecessary diagnostic procedures such as cystoscopy. ABSTRACT: Bladder cancer (BC) is the most common urological malignancy and has a high incidence of recurrence. BC cells alter their nutrient uptake and metabolic pathways in order to continue the production of sufficient levels of ATP and metabolic intermediates for proliferation and survival. Changes in metabolic pathways regarding the rate of the enzymatic reaction and transport lead to differences in the content of natural isotopes ((13)C, (15)N, (34)S) between normal and cancerous tissues. The assessment of the stable isotopes of carbon, nitrogen, and sulfur in normal urothelium and bladder cancer samples was performed using Isotope Ratio Mass Spectrometry (IRMS). The natural abundance of (15)N and (13)C was decreased in bladder cancer samples when compared to normal urothelium. No significant correlation was observed in BC specimens depending on the tumor grade and stage. Samples derived from bladder tumors and normal urothelium had a different pattern of (15)N and (13)C isotope abundance. Decreased (13)C natural isotopes in the normal urothelium of BC patients were significantly associated with a shorter DFS. Our results suggest that isotopic analysis of normal urothelium of BC patients can be used to predict bladder cancer recurrence. MDPI 2022-05-13 /pmc/articles/PMC9140021/ /pubmed/35626027 http://dx.doi.org/10.3390/cancers14102423 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Madej, Adam
Forma, Ewa
Golberg, Michał
Kamiński, Rafał
Paneth, Piotr
Kobos, Józef
Różański, Waldemar
Lipiński, Marek
(13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer
title (13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer
title_full (13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer
title_fullStr (13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer
title_full_unstemmed (13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer
title_short (13)C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer
title_sort (13)c natural isotope abundance in urothelium as a new marker in the follow-up of patients with bladder cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140021/
https://www.ncbi.nlm.nih.gov/pubmed/35626027
http://dx.doi.org/10.3390/cancers14102423
work_keys_str_mv AT madejadam 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer
AT formaewa 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer
AT golbergmichał 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer
AT kaminskirafał 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer
AT panethpiotr 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer
AT kobosjozef 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer
AT rozanskiwaldemar 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer
AT lipinskimarek 13cnaturalisotopeabundanceinurotheliumasanewmarkerinthefollowupofpatientswithbladdercancer